A case control, observational study analysing effectiveness of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Latest Information Update: 13 Oct 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 13 Oct 2021 New trial record
- 06 Oct 2021 Results published in the New England Journal of Medicine